Skip to main content

Table 1 Basic characteristics of 200 patients included in the analysis

From: Evaluation of models to predict prognosis in patients with advanced hepatocellular carcinoma treated with TACE combined with apatinib

Variable

N

(N)%

Age

  

≤ 60Y

125

62.5

> 60Y

75

37.5

Sex(n%)

  

Male

162

81.0

Female

38

19.0

Liver disease(n%)

  

Yes

140

70.0

No

60

30.0

Metastases

  

NO

128

64.0

YES

72

36.0

Child-Pugh grade(n%)

 

0.776

A

120

60.0

B

80

40.0

ALBI grade(n%)

  

1

83

41.5

2

117

58.5

AFP (n%)

  

≤ 400

116

58.0

> 400

84

42.0

Tumor (cm)

  

≤ 7

124

62.0

> 7

76

38.0

Tumor number(n%)

  

≤ 3

86

43.0

> 3

114

57.0

Ecog score (n%)

  

0–1

150

75.0

2

50

25.0

PVTT(n%)

  

I-II

119

59.5

III-IV

81

40.5

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us